FTB690 Series Starts at FTB691, $ Indicates Both Rate FTB692, $ and Total 3% Reading Accuracy All models FTB693, $ shown smaller 6-Digit Display than actual size. Reads GPM or LPM Battery Operated (Included) FTB694, $
FTB690 Series turbine meterswith microprocessor-basedelectronics offers a durable,compact, high-precision fluidmeasurement device, with total andrate indication. Information is clearlydisplayed on a large 6-digit liquid
floating decimal for totals from0.01 to 999,999. All operations areeasily performed with only 2 buttons. The basic unit and display arepowered by 2 lithium batteries,
Wetted Components: Display: 6-digit LCD, Housing: PVC Journal Bearings: Ceramic Power: Two 3V lithium Shaft: Tungsten carbide
batteries (included) Battery Life: 4000 hrs Rotor and Supports: PVDF Retaining Rings: 316 SS
A single-point field calibrationcurve can be stored in memory.
To Order (Specify M odel N um ber) Model Flowrate Price Description GPM (LPM)
replacement lithium battery for thedisplay electronics. Batteries
FTB691-NPT SPECIFICATIONS FTB692-NPT Accuracy: ±3% rdg
1" Sch. 40 socket turbine 5 to 50 (19 to 190)
Extended Low Flow Range Accuracy: ±5.0% rdg (display models only) FTB693-NPT Repeatability: ±0.1%
11⁄2" Sch. 40 socket turbine 10 to 100 (38 to 380) 1.4 (0.63)
Pressure Rating: 150 psig (10.3 bar) FTB694-NPT Temperatures:
2" Sch. 40 NPT turbine 10 to 100 (38 to 380) 1.4 (0.63)
Operational: 0 to 60°C (32 to 140°F)
2" Sch. 40 socket turbine 20 to 200 (76 to 760) 1.68 (0.76)
Storage: -40 to 70°C (-40 to158°F) FTB695-NPT Viscosity: Rated accuracy for fluids FLSC790-BATT
with viscosity of water (1 centistoke);meters with display can be used for
Com es com plete with two 3V lithium batteries and operator’s m anual.
For units with pulse output module in place of display add suffix“-P ” to m odel num ber, Pulse Output (Option): Open collector O rd erin g E xam ples: FT B 692-N P T, 3⁄4 NPT mount turbine, 2 to 20 GPM, $. FTB 693, 1" socket mount turbine, 5 to 50 GPM , $.
Novartis stellt Schweinegrippe-Impfstoff unter BeweisNach einer Pilot-Studie hat Novartis die Wirksamkeit seines Schweinegrippe-Impfstoffes unter Beweis gestellt. Der Test an 100 gesunden Probanden ergab, dass das Mittel Celtura bereits nach der ersten Dosis bei 80 Prozent der Geimpften eine starke Immunantwort auslöst. Ein vom Schweizer Novartis-Konzern entwickelter Impfstoff gegen die sogenan
Rationale: It is the policy of Bright Start Educare to ensure the health and well being of all children at our centre. Standards: All reasonable steps must be taken to ensure that any child suffering from any infectious diseases listed in schedule 2 on the Health Regulations 1966 is excluded from the centre. Any child suffering from any disease, ailment, illness or other co
FTB690 Series